117 results on '"Plazzi, G."'
Search Results
2. Effects of oxybate on sleep, sleep architecture, and disrupted nighttime sleep
3. A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD
4. Unsupervised clustering of central hypersomnolence disorders enables data-driven phenotyping: toward more reliable diagnostic criteria
5. Idling for decades: a European study on risk factors associated with long time to narcolepsy diagnosis
6. ICHOSA (Intra Cerebral Hemorrage and Obstructive Sleep Apnea) project: first results
7. Long-term safety and efficacy of daridorexant in patients with insomnia disorder
8. Heterogeneous Neuropsychiatric Symptoms and Outcome in Very Early-Onset Narcolepsy Type 1: a Case Series
9. Efficacy of long-term treatment with daridorexant in patients with insomnia disorder on sleep and daytime functioning: a post-hoc analysis
10. Residual excessive daytime sleepiness (EDS) in Italian patients with obstructive sleep apnea (OSA) treated with continuous positive airway pressure (CPAP): preliminary results of the OSAREDS study
11. Consistent skin α-synuclein positivity in REM sleep behavior disorder – A two center two-to-four-year follow-up study
12. Analysis of dominant and recessive parkinsonism genes in REM sleep behavior disorder
13. GBA variants in REM sleep behavior disorder risk and conversion: a multicenter study
14. Objective rest–activity cycle analysis by actigraphy identifies isolated rapid eye movement sleep behavior disorder
15. 0950 Effects of Sodium Oxybate (SXB) on Body Mass Index (BMI) in Pediatric Patients With Narcolepsy
16. 0941 Defining Disrupted Nighttime Sleep in Pediatric Narcolepsy
17. Long-term safety of Sodium Oxybate in paediatric narcolepsy with cataplexy: open-label continuation after 1 year of treatment
18. Validation of an eye movement detector and inter-rater variability of the manual scoring of different types of nocturnal eye movements
19. Defining disrupted nighttime sleep (DNS) in pediatric narcolepsy
20. Disorders of Motor Control and Sleep
21. The Syndrome of Nocturnal Frontal Lobe Epilepsy
22. Circadian Rhythm of Body Core Temperature in Neurodegenerative Diseases
23. Abnormal α‐synuclein deposits in skin nerves: intra‐ and inter‐laboratory reproducibility
24. A Randomized, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Solriamfetol (JZP-110) for the Treatment of Excessive Sleepiness (ES) in Participants with Narcolepsy Types 1 and 2 (NT1/2) (CT.003)
25. 0618 Cerebrospinal Fluid Biomarkers in Kleine-Levin syndrome
26. 0838 Clinical and Patient Global Impression in a Phase 2/3 Study of Sodium Oxybate in Children and Adolescents with Narcolepsy with Cataplexy
27. 0619 Solriamfetol (JZP-110) for Treatment of Excessive Sleepiness in Narcoleptic Patients With and Without Cataplexy: Results From a Randomized, Phase 3, Clinical Trial
28. 0684 Identification of Novel Candidate Biomarkers for RBD by Proteomic Analysis
29. 0813 Sodium Oxybate Treatment of Narcolepsy in Pediatric Patients: Long-term Efficacy and Safety
30. 0837 Pharmacokinetics of Sodium Oxybate in Children and Adolescents with Narcolepsy with Cataplexy
31. 0621 Measures of Function, Work Productivity, and Quality of Life From a Phase 3 Study of Solriamfetol (JZP-110) in Patients with Narcolepsy
32. Intérêt de l’oxybate de sodium (SOB) dans la narcolepsie pédiatrique : étude multicentrique en double aveugle, randomisée, contrôlée contre placebo
33. Méta-analyse en réseau comparant les traitements de la narcolepsie
34. Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy
35. Type 1 narcolepsy in anti-Hu antibodies mediated encephalitis: a case report
36. REM sleep-related episodes in children with narcolepsy type 1 after treatment with sodium oxybate
37. A standardized test to document cataplexy
38. A double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of sodium oxybate in pediatric subjects with narcolepsy with cataplexy
39. Tolerance and pharmacokinetics of pitolisant (WAKIX®), a histamine H3 antagonist, in 24 narcoleptic children
40. Narcolepsy treatments: comparison of pitolisant, modafinil and sodium oxybate via a network meta-analysis
41. Aspects of functioning in people with narcolepsy identified by the ICF core set for sleep disorders: preliminary results
42. The distinguishing motor features of cataplexy: a study from video recorded attacks
43. Stereotyped episodes of aphasia and immobility: how cataplexy mimics stroke in an elderly patient
44. 0729 EFFECTS OF CHRONIC CLONAZEPAM ADMINISTRATION ON REM SLEEP INSTABILITY IN RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER
45. 0645 A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, MULTICENTER STUDY ON THE EFFICACY AND SAFETY OF SODIUM OXYBATE IN PEDIATRIC SUBJECTS WITH NARCOLEPSY WITH CATAPLEXY
46. Spectral electroencephalography profile of rapid eye movement sleep at sleep onset in narcolepsy type 1
47. World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG)
48. Age-related differences in sleep-dependent consolidation of motor skills in patients with narcolepsy type 1
49. 46. Abnormal sympathetic and cardiovascular reactivity during mental stress in patients with narcolepsy and cataplexy
50. Dissociated rapid eye movement sleep dream experiences in type 1 narcolepsy: a case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.